首页 > 最新文献

Journal of Infection最新文献

英文 中文
A nationwide genomic surveillance study of Gram-negative bacteria causing community- and hospital-acquired bloodstream infections in China 中国引起社区和医院获得性血液感染的革兰氏阴性菌的全国基因组监测研究
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 DOI: 10.1016/j.jinf.2026.106693
Jingyuan Xi , Xinmiao Jia , Song Li , Xuming Li , Long Hu , Han Xia , Tao Xu , Yingchun Xu , Yunsong Yu , Fupin Hu , Mei Kang , Ziyong Sun , Lijuan Ma , Bin Shan , Xiaoling Ma , Mingxiang Zou , Jihong Li , Chaolu Hasi , Yong Liu , Dawen Guo , Qiwen Yang

Objectives

Community-acquired and hospital-acquired bloodstream infections (CA-BSI and HA-BSI) caused by Gram-negative bacteria (GNB) pose major clinical risks, but differences in their molecular epidemiology and prognostic etiologic factors remain unclear.

Methods

A genomic epidemiology study analyzed 933 CA-BSI and 1001 HA-BSI isolates from 21 major Chinese teaching hospitals. We collected comprehensive clinical data and conducted molecular characterization, including sequence types, antibiotic resistance genes, virulence factors, and plasmid types, as well as clinical phenotypes of major pathogens. Multivariable Cox models were used to identify mortality predictors.

Results

Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacter cloacae complex were the predominant species in both CA-BSI and HA-BSI groups but exhibited distinct clinical and molecular characteristics between CA-BSI and HA-BSI. CA-BSI patients showed significantly higher inflammatory markers (CRP, PCT, WBC, and Neu%), while HA-BSI patients had significantly poorer prognosis including prolonged hospitalization, higher ICU admission rates and clinical deterioration or mortality. Genomic surveillance revealed a critical divergence: HA isolates were dominated by high-risk clones such as ST11 K. pneumoniae and ST2 A. baumannii, which were enriched in antimicrobial resistance genes, directly linking to worse outcomes. CA isolates, while more diverse, were characterized by specific lineages including ST131 E. coli (enriched with specific virulence genes: yersiniabactin, K1 capsule, and P fimbriae) and ST23 K. pneumoniae, which carried a significantly greater number of virulence genes. Multivariable analysis confirmed that mortality risk profiles are setting-specific, influenced by distinct combinations of patient comorbidities (including age, gender, agranulocytosis, and infection source) and bacterial genetic determinants (such as lacI or aadA2 for K. pneumoniae and aph(3′)-Ia for A. baumannii).

Conclusions

This first genomic epidemiological investigation of GNB-BSIs stratified by acquisition setting reveals a fundamental clinical and epidemiological divergence between CA- and HA-cases. The study underscores that tracking mortality-associated strains and genes is essential for improving clinical outcomes and advancing etiological knowledge.
目的:革兰氏阴性菌(GNB)引起的社区获得性和医院获得性血流感染(CA-BSI和HA-BSI)具有重大的临床风险,但其分子流行病学和预后病因的差异尚不清楚。方法:采用基因组流行病学方法对21所中国重点教学医院的933株CA-BSI和1001株HA-BSI进行分析。我们收集了全面的临床资料,并进行了分子表征,包括序列类型、抗生素耐药基因、毒力因子、质粒类型,以及主要病原体的临床表型。采用多变量Cox模型确定死亡率预测因子。结果:大肠杆菌、肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌和阴沟肠杆菌是CA-BSI组和HA-BSI组的优势菌种,但CA-BSI组和HA-BSI组表现出不同的临床和分子特征。CA-BSI患者的炎症标志物(CRP、PCT、WBC和Neu%)明显较高,而HA-BSI患者的预后明显较差,包括住院时间延长、ICU入院率较高、临床恶化或死亡。基因组监测揭示了一个关键的分歧:HA分离物主要是高风险克隆,如ST11肺炎克雷伯菌和ST2鲍曼尼杆菌,它们富含抗微生物药物抗性基因,将其流行病学与更糟糕的结果直接联系起来。CA分离株虽然更加多样化,但其特点是具有特定的谱系,包括ST131大肠杆菌(富含特定的毒力基因:耶尔希尼abactin、K1胶囊和P菌毛)和ST23肺炎克雷伯菌,后者携带的毒力基因数量明显更多。多变量分析证实,死亡风险谱是特定环境的,受患者合并症(包括年龄、性别、粒细胞缺血症和感染源)和细菌遗传决定因素(如肺炎克雷伯菌的lacI或aadA2,鲍曼不动杆菌的aph(3′)-Ia)的不同组合影响。结论:对gnb - bsi进行的首次基因组流行病学调查揭示了CA-和ha -病例之间的基本临床和流行病学差异。该研究强调,追踪与死亡率相关的菌株和基因对于改善临床结果和推进病因学知识至关重要。
{"title":"A nationwide genomic surveillance study of Gram-negative bacteria causing community- and hospital-acquired bloodstream infections in China","authors":"Jingyuan Xi ,&nbsp;Xinmiao Jia ,&nbsp;Song Li ,&nbsp;Xuming Li ,&nbsp;Long Hu ,&nbsp;Han Xia ,&nbsp;Tao Xu ,&nbsp;Yingchun Xu ,&nbsp;Yunsong Yu ,&nbsp;Fupin Hu ,&nbsp;Mei Kang ,&nbsp;Ziyong Sun ,&nbsp;Lijuan Ma ,&nbsp;Bin Shan ,&nbsp;Xiaoling Ma ,&nbsp;Mingxiang Zou ,&nbsp;Jihong Li ,&nbsp;Chaolu Hasi ,&nbsp;Yong Liu ,&nbsp;Dawen Guo ,&nbsp;Qiwen Yang","doi":"10.1016/j.jinf.2026.106693","DOIUrl":"10.1016/j.jinf.2026.106693","url":null,"abstract":"<div><h3>Objectives</h3><div>Community-acquired and hospital-acquired bloodstream infections (CA-BSI and HA-BSI) caused by Gram-negative bacteria (GNB) pose major clinical risks, but differences in their molecular epidemiology and prognostic etiologic factors remain unclear.</div></div><div><h3>Methods</h3><div>A genomic epidemiology study analyzed 933 CA-BSI and 1001 HA-BSI isolates from 21 major Chinese teaching hospitals. We collected comprehensive clinical data and conducted molecular characterization, including sequence types, antibiotic resistance genes, virulence factors, and plasmid types, as well as clinical phenotypes of major pathogens. Multivariable Cox models were used to identify mortality predictors.</div></div><div><h3>Results</h3><div><em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas aeruginosa</em>, <em>Acinetobacter baumannii</em>, and <em>Enterobacter cloacae</em> complex were the predominant species in both CA-BSI and HA-BSI groups but exhibited distinct clinical and molecular characteristics between CA-BSI and HA-BSI. CA-BSI patients showed significantly higher inflammatory markers (CRP, PCT, WBC, and Neu%), while HA-BSI patients had significantly poorer prognosis including prolonged hospitalization, higher ICU admission rates and clinical deterioration or mortality. Genomic surveillance revealed a critical divergence: HA isolates were dominated by high-risk clones such as ST11 <em>K. pneumoniae</em> and ST2 <em>A. baumannii</em>, which were enriched in antimicrobial resistance genes, directly linking to worse outcomes. CA isolates, while more diverse, were characterized by specific lineages including ST131 <em>E. coli</em> (enriched with specific virulence genes: yersiniabactin, K1 capsule, and P fimbriae) and ST23 <em>K. pneumoniae</em>, which carried a significantly greater number of virulence genes. Multivariable analysis confirmed that mortality risk profiles are setting-specific, influenced by distinct combinations of patient comorbidities (including age, gender, agranulocytosis, and infection source) and bacterial genetic determinants (such as <em>lacI</em> or <em>aadA2</em> for <em>K. pneumoniae</em> and <em>aph(3′)-Ia</em> for <em>A. baumannii</em>).</div></div><div><h3>Conclusions</h3><div>This first genomic epidemiological investigation of GNB-BSIs stratified by acquisition setting reveals a fundamental clinical and epidemiological divergence between CA- and HA-cases. The study underscores that tracking mortality-associated strains and genes is essential for improving clinical outcomes and advancing etiological knowledge.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106693"},"PeriodicalIF":11.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A five-year multicentre evaluation of candidaemia in UK adults: Epidemiology, risk factors and outcomes. 英国成人念珠菌血症的5年多中心评估流行病学、危险因素和结果。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2026-01-20 DOI: 10.1016/j.jinf.2026.106692
C Logan, P Allebone-Salt, A Mazzella, C Hemsley, A Goodman, C Ward, A Fife, S Schelenz, A Abdolrasouli, T Bicanic

Objectives: To evaluate the epidemiology and outcomes of candidaemia in hospitalised adults METHODS: A five-year (January 2015-December 2019) retrospective multi-site evaluation of candidaemia episodes in hospitalised adults at three London hospitals to assess Candida species, infection source, antifungal resistance, management and mortality.

Results: 342 episodes of candidaemia in 333 patients were recorded. Common predisposing risk factors for candidaemia included vascular catheters, abdominal surgery, malignancy and diabetes. Candida albicans (36%), Candida glabrata/ Nakaseomyces glabratus (35%), and Candida parapsilosis (13%), were the most common causative species, with N. glabratus and C. parapsilosis associated with abdominal and line-related sources respectively. Fluconazole resistance was observed in 14% of isolates, while echinocandin resistance was rare (3%). Candida endocarditis and ocular candidiasis occurred in 5.2% and 2.6% of those assessed respectively; both were associated with persistent candidaemia (≥2 successive days). All-cause 30-day mortality was 32%. Age>60 years, liver disease, malignancy, non-removable source of candidaemia and lack of initial echinocandin therapy were independent baseline predictors of mortality.

Conclusions: Candidaemia is a significant healthcare-associated infection with high mortality, particularly in ICU patients with difficult-to-clear foci. The rise of N. glabratus is concerning given its propensity for antifungal resistance. Future clinical and research priorities include better diagnostic tools and refinement of antifungal treatment strategies.

目的:评估住院成人念珠菌血症的流行病学和结局方法:对伦敦三家医院住院成人念珠菌血症发作进行为期五年(2015年1月至2019年12月)的回顾性多地点评估,以评估念珠菌种类、感染源、抗真菌耐药性、管理和死亡率。结果:333例患者发生342次念珠菌血症。念珠菌血症的常见易感危险因素包括血管导管、腹部手术、恶性肿瘤和糖尿病。白色念珠菌(36%)、光秃念珠菌/光秃中丝酵母菌(35%)和副假丝酵母菌(13%)是最常见的致病菌,其中光秃念珠菌和副假丝酵母菌分别与腹部和细胞系相关。14%的分离株对氟康唑耐药,而棘白菌素耐药罕见(3%)。念珠菌心内膜炎和眼念珠菌病的发生率分别为5.2%和2.6%;两者均伴有持续性念珠菌血症(≥连续2天)。全因30天死亡率为32%。年龄0 ~ 60岁、肝脏疾病、恶性肿瘤、不可清除的念珠菌血症来源和缺乏最初的刺白菌素治疗是死亡率的独立基线预测因素。结论:念珠菌血症是一种重要的卫生保健相关感染,死亡率高,特别是在难以清除病灶的ICU患者中。鉴于其抗真菌抗性的倾向,毛霉的崛起令人担忧。未来的临床和研究重点包括更好的诊断工具和抗真菌治疗策略的改进。
{"title":"A five-year multicentre evaluation of candidaemia in UK adults: Epidemiology, risk factors and outcomes.","authors":"C Logan, P Allebone-Salt, A Mazzella, C Hemsley, A Goodman, C Ward, A Fife, S Schelenz, A Abdolrasouli, T Bicanic","doi":"10.1016/j.jinf.2026.106692","DOIUrl":"10.1016/j.jinf.2026.106692","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the epidemiology and outcomes of candidaemia in hospitalised adults METHODS: A five-year (January 2015-December 2019) retrospective multi-site evaluation of candidaemia episodes in hospitalised adults at three London hospitals to assess Candida species, infection source, antifungal resistance, management and mortality.</p><p><strong>Results: </strong>342 episodes of candidaemia in 333 patients were recorded. Common predisposing risk factors for candidaemia included vascular catheters, abdominal surgery, malignancy and diabetes. Candida albicans (36%), Candida glabrata/ Nakaseomyces glabratus (35%), and Candida parapsilosis (13%), were the most common causative species, with N. glabratus and C. parapsilosis associated with abdominal and line-related sources respectively. Fluconazole resistance was observed in 14% of isolates, while echinocandin resistance was rare (3%). Candida endocarditis and ocular candidiasis occurred in 5.2% and 2.6% of those assessed respectively; both were associated with persistent candidaemia (≥2 successive days). All-cause 30-day mortality was 32%. Age>60 years, liver disease, malignancy, non-removable source of candidaemia and lack of initial echinocandin therapy were independent baseline predictors of mortality.</p><p><strong>Conclusions: </strong>Candidaemia is a significant healthcare-associated infection with high mortality, particularly in ICU patients with difficult-to-clear foci. The rise of N. glabratus is concerning given its propensity for antifungal resistance. Future clinical and research priorities include better diagnostic tools and refinement of antifungal treatment strategies.</p>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":" ","pages":"106692"},"PeriodicalIF":11.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to: Comment on: Detection of tick-borne encephalitis virus RNA in patient samples at different stages of infection 对不同感染阶段患者样本中蜱传脑炎病毒RNA检测的评论。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 DOI: 10.1016/j.jinf.2026.106694
Michal Frantisek Kriha, Jan Kamis, Marketa Dvorakova, Luc Tardy, Jana Elsterova, Dana Teislerova, Ales Chrdle, Martin Palus, Daniel Ruzek, Vaclav Hönig
{"title":"Response to: Comment on: Detection of tick-borne encephalitis virus RNA in patient samples at different stages of infection","authors":"Michal Frantisek Kriha,&nbsp;Jan Kamis,&nbsp;Marketa Dvorakova,&nbsp;Luc Tardy,&nbsp;Jana Elsterova,&nbsp;Dana Teislerova,&nbsp;Ales Chrdle,&nbsp;Martin Palus,&nbsp;Daniel Ruzek,&nbsp;Vaclav Hönig","doi":"10.1016/j.jinf.2026.106694","DOIUrl":"10.1016/j.jinf.2026.106694","url":null,"abstract":"","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106694"},"PeriodicalIF":11.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative cross-species transcriptomics during RSV infection identifies targets to treat RSV disease. 比较RSV感染期间的跨物种转录组学确定治疗RSV疾病的靶标。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-31 DOI: 10.1016/j.jinf.2026.106696
Ziyin Wang, Claire Dunican, Pete Dayananda, Suhaylah Ingar, Myrsini Kaforou, Christopher Chiu, John S Tregoning

Respiratory syncytial virus (RSV) remains a health threat to young children worldwide. The host immune response plays a key role in disease following infection. Infection models advance our understanding of respiratory viruses, but individual models have gaps, which overlapping complementary systems can fill. We compared disease signatures in mice, adults and children; combining transcriptomic data collected from blood, nasal mucosa and lung biopsy following RSV infection. We identified both shared and species-specific pathways triggered by RSV. While systemic responses in children's blood were more similar to those in RSV-challenged adults, mucosal responses during primary infection in mice more closely resembled those in children. We identified an association between IL-17 pathways and RSV pathogenesis and with over-expression of the downstream effectors S100A8 and S100A9. Inhibiting these with the anti-inflammatory drug Paquinimod reduced disease. Here we demonstrate that integrating mouse and human transcriptomic data can identify novel targets to treat RSV disease.

呼吸道合胞病毒(RSV)仍然是全世界幼儿的一大健康威胁。宿主免疫反应在感染后的疾病中起着关键作用。感染模型促进了我们对呼吸道病毒的理解,但单个模型存在空白,重叠的互补系统可以填补空白。我们比较了小鼠、成人和儿童的疾病特征;结合RSV感染后血液、鼻黏膜和肺活检收集的转录组学数据。我们确定了RSV触发的共享途径和物种特异性途径。虽然儿童血液中的全身反应与rsv感染的成人更相似,但小鼠原发性感染期间的粘膜反应与儿童更相似。我们确定了IL-17通路与RSV发病机制以及下游效应物S100A8和S100A9的过表达之间的关联。用消炎药帕喹尼mod抑制这些可以减少疾病。在这里,我们证明整合小鼠和人类转录组学数据可以确定治疗RSV疾病的新靶点。
{"title":"Comparative cross-species transcriptomics during RSV infection identifies targets to treat RSV disease.","authors":"Ziyin Wang, Claire Dunican, Pete Dayananda, Suhaylah Ingar, Myrsini Kaforou, Christopher Chiu, John S Tregoning","doi":"10.1016/j.jinf.2026.106696","DOIUrl":"https://doi.org/10.1016/j.jinf.2026.106696","url":null,"abstract":"<p><p>Respiratory syncytial virus (RSV) remains a health threat to young children worldwide. The host immune response plays a key role in disease following infection. Infection models advance our understanding of respiratory viruses, but individual models have gaps, which overlapping complementary systems can fill. We compared disease signatures in mice, adults and children; combining transcriptomic data collected from blood, nasal mucosa and lung biopsy following RSV infection. We identified both shared and species-specific pathways triggered by RSV. While systemic responses in children's blood were more similar to those in RSV-challenged adults, mucosal responses during primary infection in mice more closely resembled those in children. We identified an association between IL-17 pathways and RSV pathogenesis and with over-expression of the downstream effectors S100A8 and S100A9. Inhibiting these with the anti-inflammatory drug Paquinimod reduced disease. Here we demonstrate that integrating mouse and human transcriptomic data can identify novel targets to treat RSV disease.</p>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":" ","pages":"106696"},"PeriodicalIF":11.9,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global frequency of Campylobacter-associated hospitalisations: A systematic review and meta-analyses 弯曲杆菌相关住院的全球频率:系统回顾和荟萃分析
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-30 DOI: 10.1016/j.jinf.2026.106695
Thomas J. Callaghan , Colleen L. Lau , Suhail A. Doi , James J. Smith , Uttara Kennedy , Francisca Powell-Romero , Dwan Vilcins , Rowland N. Cobbold , Amy V. Jennison , Shovon Chakma , Robin Sherlock , Ricardo J. Soares Magalhães
<div><h3>Background</h3><div>A minority of <em>Campylobacter</em> infections cause severe morbidity, yet admission rates for patients requiring hospital-based treatment are poorly understood. Our study aimed to quantify the percentage of <em>Campylobacter</em> infections requiring hospitalisation and determine variation by patient subgroups.</div></div><div><h3>Methods</h3><div>Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we performed a systematic review and meta-analyses of globally reported hospitalisation frequencies for <em>Campylobacter</em> infections. We performed a risk of bias assessment, followed by meta-analyses under the assumption of common parameters. Results were interpreted from the Quality Effects (QE) models in MetaXL and the heterogeneity of included studies assessed using chi-square tests. In addition to the primary meta-analysis for <em>Campylobacter</em> infections overall, we conducted subgroup analyses by <em>Campylobacter</em> species, demographic group, clinical group, antimicrobial resistance (AMR) status, start decade of cases and event type (sporadic or outbreak-associated). The study was registered with PROSPERO (CRD42023493466).</div></div><div><h3>Findings</h3><div>A total of 137 articles (containing 235 studies) published from 1979 to 2025 were eligible for meta-analysis. These publications contained 1,377,770 <em>Campylobacter</em> infections for 946 patient groups (data points), primarily from North America, Europe and Oceania. In the pooled analysis of hospitalisation frequencies for <em>Campylobacter</em> infections, 13.8% (95% CI 9.6–18.6) of individuals were hospitalised. Steady increases in hospitalisation frequency were observed over time. In a pooled analysis of data from three studies, species other than <em>C. jejuni</em> or <em>C. coli</em> were associated with a higher frequency of hospitalisation (27.3%; 95% CI 11.0–47.2). Pooled hospitalisation frequencies of males (6.4%; 95% CI 1.4–14.1) and females (6.8%; 95% CI 1.5–15.0) were similar, and patients aged ≥65 years (27.9%; 95% CI 13.5–45.0) and children <1 year old (15.6%; 95% CI 9.8–22.4) were hospitalised more often compared to other age groups. Patients with pre-existing conditions were at higher risk of hospitalisation (37.1%; 95% CI 13.4–64.2). Older age, comorbidities and infection with <em>C. fetus</em> were often associated with bacteraemia. Where bacteraemia was identified, most patients were hospitalised (89.5%; 95% CI 79.6–96.5). Hospitalisations were overrepresented amongst tetracycline-resistant <em>Campylobacter</em> infections (24.4% hospitalised; 95% CI 21.4–27.5). Cases associated with outbreaks were much less likely (4.2%; 95% CI 1.7–7.6) to be hospitalised compared to sporadic cases (16.1%; 95% CI 8.1–26.1).</div></div><div><h3>Interpretation</h3><div>While most patients with <em>Campylobacter</em> infections are not hospitalised, vulnerable groups such as the very young, older a
背景:少数弯曲杆菌感染会导致严重的发病率,但需要住院治疗的患者的住院率尚不清楚。我们的研究旨在量化需要住院治疗的弯曲杆菌感染的百分比,并确定患者亚组的变化。方法:使用系统评价和荟萃分析(PRISMA)指南的首选报告项目,我们对全球报告的弯曲杆菌感染住院频率进行了系统评价和荟萃分析。我们进行了偏倚风险评估,然后在共同参数假设下进行了荟萃分析。结果通过MetaXL中的质量效应(QE)模型进行解释,并使用卡方检验评估纳入研究的异质性。除了弯曲杆菌感染总体的主要荟萃分析外,我们还根据弯曲杆菌种类、人口统计学组、临床组、抗菌素耐药性(AMR)状态、病例开始十年和事件类型(散发或爆发相关)进行了亚组分析。该研究已在PROSPERO注册(CRD42023493466)。结果:从1979-2025年共发表137篇文章(包含235项研究)符合meta分析。这些出版物包含946个患者组(数据点)的1,377,770例弯曲杆菌感染,主要来自北美、欧洲和大洋洲。在弯曲杆菌感染住院频率的汇总分析中,13.8% (95% CI 9.6-18.6)的个体住院。随着时间的推移,观察到住院频率稳步增加。在对三项研究数据的汇总分析中,除空肠梭菌或大肠梭菌外的其他物种与更高的住院频率相关(27.3%;95% CI 11.0-47.2)。男性(6.4%,95% CI 1.4-14.1)和女性(6.8%,95% CI 1.5-15.0)的合并住院频率相似,年龄≥65岁的患者(27.9%,95% CI 13.5-45.0)和< 1岁的儿童(15.6%,95% CI 9.8-22.4)比其他年龄组更常住院。已有疾病的患者住院的风险更高(37.1%;95% CI 13.4-64.2)。老年、合并症和C.胎儿感染常与菌血症有关。在发现菌血症时,大多数患者住院(89.5%;95% CI 79.6-96.5)。在四环素耐药弯曲杆菌感染中,住院率过高(24.4%住院;95% CI 21.4-27.5)。与散发性病例(16.1%,95% CI 8.1-26.1)相比,与暴发相关的病例住院的可能性要小得多(4.2%;95% CI 1.7-7.6)。解释:虽然大多数弯曲杆菌感染患者不住院,但弱势群体,如幼儿、老年人和有合并症的人更有可能住院。随着时间的推移,住院频率的增加加强了解决这一负担的迫切需要,即优先考虑针对弱势人群中弯曲杆菌暴露的研究和干预措施。资助:T . J . Callaghan获得了澳大利亚政府研究培训计划奖学金。C L Lau得到了澳大利亚国家卫生和医学研究委员会调查员补助金(1193826)的资助。
{"title":"Global frequency of Campylobacter-associated hospitalisations: A systematic review and meta-analyses","authors":"Thomas J. Callaghan ,&nbsp;Colleen L. Lau ,&nbsp;Suhail A. Doi ,&nbsp;James J. Smith ,&nbsp;Uttara Kennedy ,&nbsp;Francisca Powell-Romero ,&nbsp;Dwan Vilcins ,&nbsp;Rowland N. Cobbold ,&nbsp;Amy V. Jennison ,&nbsp;Shovon Chakma ,&nbsp;Robin Sherlock ,&nbsp;Ricardo J. Soares Magalhães","doi":"10.1016/j.jinf.2026.106695","DOIUrl":"10.1016/j.jinf.2026.106695","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;A minority of &lt;em&gt;Campylobacter&lt;/em&gt; infections cause severe morbidity, yet admission rates for patients requiring hospital-based treatment are poorly understood. Our study aimed to quantify the percentage of &lt;em&gt;Campylobacter&lt;/em&gt; infections requiring hospitalisation and determine variation by patient subgroups.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we performed a systematic review and meta-analyses of globally reported hospitalisation frequencies for &lt;em&gt;Campylobacter&lt;/em&gt; infections. We performed a risk of bias assessment, followed by meta-analyses under the assumption of common parameters. Results were interpreted from the Quality Effects (QE) models in MetaXL and the heterogeneity of included studies assessed using chi-square tests. In addition to the primary meta-analysis for &lt;em&gt;Campylobacter&lt;/em&gt; infections overall, we conducted subgroup analyses by &lt;em&gt;Campylobacter&lt;/em&gt; species, demographic group, clinical group, antimicrobial resistance (AMR) status, start decade of cases and event type (sporadic or outbreak-associated). The study was registered with PROSPERO (CRD42023493466).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;div&gt;A total of 137 articles (containing 235 studies) published from 1979 to 2025 were eligible for meta-analysis. These publications contained 1,377,770 &lt;em&gt;Campylobacter&lt;/em&gt; infections for 946 patient groups (data points), primarily from North America, Europe and Oceania. In the pooled analysis of hospitalisation frequencies for &lt;em&gt;Campylobacter&lt;/em&gt; infections, 13.8% (95% CI 9.6–18.6) of individuals were hospitalised. Steady increases in hospitalisation frequency were observed over time. In a pooled analysis of data from three studies, species other than &lt;em&gt;C. jejuni&lt;/em&gt; or &lt;em&gt;C. coli&lt;/em&gt; were associated with a higher frequency of hospitalisation (27.3%; 95% CI 11.0–47.2). Pooled hospitalisation frequencies of males (6.4%; 95% CI 1.4–14.1) and females (6.8%; 95% CI 1.5–15.0) were similar, and patients aged ≥65 years (27.9%; 95% CI 13.5–45.0) and children &lt;1 year old (15.6%; 95% CI 9.8–22.4) were hospitalised more often compared to other age groups. Patients with pre-existing conditions were at higher risk of hospitalisation (37.1%; 95% CI 13.4–64.2). Older age, comorbidities and infection with &lt;em&gt;C. fetus&lt;/em&gt; were often associated with bacteraemia. Where bacteraemia was identified, most patients were hospitalised (89.5%; 95% CI 79.6–96.5). Hospitalisations were overrepresented amongst tetracycline-resistant &lt;em&gt;Campylobacter&lt;/em&gt; infections (24.4% hospitalised; 95% CI 21.4–27.5). Cases associated with outbreaks were much less likely (4.2%; 95% CI 1.7–7.6) to be hospitalised compared to sporadic cases (16.1%; 95% CI 8.1–26.1).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;div&gt;While most patients with &lt;em&gt;Campylobacter&lt;/em&gt; infections are not hospitalised, vulnerable groups such as the very young, older a","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 3","pages":"Article 106695"},"PeriodicalIF":11.9,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants 在婴儿干血斑上使用微采样监测广泛中和的HIV抗体浓度。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-16 DOI: 10.1016/j.jinf.2026.106679
Rémi Latour , Nonhlanhla N. Mkhize , Ségolène Debiesse , Sashkia R. Balla , Mqondisi Tshabalala , Frances Ayres , Zanele Makhado , Priscilla Biswas , Logashvari Naidoo , Stefania Dispinseri , Trisha Ramraj , Nicolas Nagot , Lucio Gama , Ameena Goga , Gabriella Scarlatti , Yoann Cazaubon , Philippe Van de Perre , Penny L. Moore , Jean-Pierre Molès

Objectives

The use of broadly neutralising antibodies (bNAb) to prevent HIV infection is under active investigation, including for the prevention of vertical HIV transmission. In neonates, an uncomplicated sampling method for blood collection is the use of dried blood spots (DBS). We aimed to validate the use of a combination of DBS with ELISA techniques to monitor bNAb concentrations, namely VRC07-523LS and CAP256V2LS, in neonates.

Methods

We evaluated the performance of various DBS elution protocols on spiked adult blood and next on spiked cord blood. The optimised method was validated on blood from infants injected with bNAbs.

Results

After selecting the best elution conditions, we reported good repeatability and reproducibility for both bNAbs in cord blood samples. The concordance study with infant receiving VRC07-523LS or CAP256V2LS samples showed that the values obtained from DBS eluates were closely aligned with those from plasma samples and when corrected by the haematocrit value, the number of outliers was 10.1% with a positive bias of 0.35 µg/mL for CAP256V2LS, and 5.0% with a positive bias of 3 µg/mL for VRC07-523LS.

Conclusions

DBS microsampling allows accurate bNAb concentration measure in neonates, which will facilitate on-going paediatric clinical trials and possible subsequent monitoring in adults with home-sampling if deployed at scale.
目的:广泛中和抗体(bNAb)用于预防艾滋病毒感染的研究正在积极进行,包括用于预防艾滋病毒垂直传播。在新生儿中,一种简单的采血方法是使用干血点(DBS)。我们的目的是验证DBS与ELISA技术联合用于监测新生儿bNAb浓度,即VRC07-523LS和CAP256V2LS。方法:我们评估了各种DBS洗脱方案对加尖成人血的性能,其次是对加尖脐带血的性能。优化后的方法在注射了bNAbs的婴儿血液中进行了验证。结果:在选择最佳洗脱条件后,我们报告了脐带血样品中两种bnab的重复性和再现性良好。对接受VRC07-523LS或CAP256V2LS样品的婴儿进行的一致性研究表明,DBS洗脱液获得的值与血浆样品的值密切一致,当用红细胞压压值进行校正时,异常值的数量为10.1%,CAP256V2LS为0.35µg/mL,而VRC07-523LS为5.0%,正偏差为3µg/mL。结论:DBS微采样可以对新生儿进行准确的bNAb浓度测量,如果大规模部署,这将促进正在进行的儿科临床试验和可能的后续成人家庭采样监测。
{"title":"Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants","authors":"Rémi Latour ,&nbsp;Nonhlanhla N. Mkhize ,&nbsp;Ségolène Debiesse ,&nbsp;Sashkia R. Balla ,&nbsp;Mqondisi Tshabalala ,&nbsp;Frances Ayres ,&nbsp;Zanele Makhado ,&nbsp;Priscilla Biswas ,&nbsp;Logashvari Naidoo ,&nbsp;Stefania Dispinseri ,&nbsp;Trisha Ramraj ,&nbsp;Nicolas Nagot ,&nbsp;Lucio Gama ,&nbsp;Ameena Goga ,&nbsp;Gabriella Scarlatti ,&nbsp;Yoann Cazaubon ,&nbsp;Philippe Van de Perre ,&nbsp;Penny L. Moore ,&nbsp;Jean-Pierre Molès","doi":"10.1016/j.jinf.2026.106679","DOIUrl":"10.1016/j.jinf.2026.106679","url":null,"abstract":"<div><h3>Objectives</h3><div>The use of broadly neutralising antibodies (bNAb) to prevent HIV infection is under active investigation, including for the prevention of vertical HIV transmission. In neonates, an uncomplicated sampling method for blood collection is the use of dried blood spots (DBS). We aimed to validate the use of a combination of DBS with ELISA techniques to monitor bNAb concentrations, namely VRC07-523LS and CAP256V2LS, in neonates.</div></div><div><h3>Methods</h3><div>We evaluated the performance of various DBS elution protocols on spiked adult blood and next on spiked cord blood. The optimised method was validated on blood from infants injected with bNAbs.</div></div><div><h3>Results</h3><div>After selecting the best elution conditions, we reported good repeatability and reproducibility for both bNAbs in cord blood samples. The concordance study with infant receiving VRC07-523LS or CAP256V2LS samples showed that the values obtained from DBS eluates were closely aligned with those from plasma samples and when corrected by the haematocrit value, the number of outliers was 10.1% with a positive bias of 0.35 µg/mL for CAP256V2LS, and 5.0% with a positive bias of 3 µg/mL for VRC07-523LS.</div></div><div><h3>Conclusions</h3><div>DBS microsampling allows accurate bNAb concentration measure in neonates, which will facilitate on-going paediatric clinical trials and possible subsequent monitoring in adults with home-sampling if deployed at scale.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106679"},"PeriodicalIF":11.9,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study 遗传性出血性毛细血管扩张患者细菌感染的当代图景:一项全国性队列研究。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-14 DOI: 10.1016/j.jinf.2026.106686
Eloïse Le Banner , Joseph Le Moulec , Mallorie Kerjouan , Vincent Grosbost , Antoine Parrot , Murielle Rondeau-Lutz , Vanessa Leguy Seguin , Christian Lavigne , Anne Contis , Morgane Mourguet , Shirine Mohamed , Étienne-Marie Jutant , Sandra Blivet , Johana Pradelli , Olivier Espitia , Laurent Chaussavoine , Sabine Revuz , Matthieu Revest , Pierre Tattevin , Sophie Dupuis-Girod , David Luque Paz

Objectives

Patients with hereditary hemorrhagic telangiectasia (HHT) present increased risk of severe infections. Studies focusing on infections in HHT population are scarce. We aimed to assess characteristics and outcomes of infections in patients with HHT.

Methods

A retrospective study was conducted in a nationwide cohort of 4502 HHT patients. Patients with HHT hospitalized for infection across 16 referral centers in France between 2010 and 2024 were identified, and data were collected through a standardized questionnaire.

Results

We included 163 HHT patients (median age, 60 years [49–69], 52% male), who experienced a total of 249 bacterial infections. One third (n=53/163) experienced recurrent infections requiring hospitalization. Infections caused by Staphylococcus aureus were reported in 80 patients representing 107 episodes of infection. Brain abscesses were reported in 43 patients representing 51 episodes, often despite prior pulmonary arteriovenous malformations embolization (n=17/43). In multivariable analysis, factors associated with 1-year mortality (n=27/163, 17%) were age (aHR=1.06, 95%CI:1.01–1.16) and infective endocarditis (aHR=2.88, 95%CI:1.10–7.87).

Conclusions

In this HHT cohort, severe infections were predominantly due to S. aureus, far ahead of brain abscesses caused by oral bacteria. Considering the high rate of recurrent infections, further studies focusing on prophylaxis strategies in HHT patients are needed.
目的:遗传性出血性毛细血管扩张(HHT)患者出现严重感染的风险增加。关注HHT人群感染的研究很少。我们的目的是评估HHT患者感染的特征和结果。方法:对全国4502例HHT患者进行回顾性研究。在2010年至2024年期间,法国16个转诊中心的HHT患者因感染住院,并通过标准化问卷收集数据。结果:我们纳入163例HHT患者(中位年龄60岁[49-69],52%为男性),共发生249例细菌感染。1 / 3 (n=53/163)出现复发性感染,需要住院治疗。报告了由金黄色葡萄球菌引起的感染,80例患者共发生107次感染。脑脓肿报告了43例患者,共51次发作,通常尽管先前有肺动静脉畸形栓塞(n=17/43)。在多变量分析中,与1年死亡率(n=27/163, 17%)相关的因素是年龄(aHR=1.06, 95%CI:1.01-1.16)和感染性心内膜炎(aHR=2.88, 95%CI:1.10-7.87)。结论:在这个HHT队列中,严重感染主要是由金黄色葡萄球菌引起的,远远超过由口腔细菌引起的脑脓肿。鉴于HHT患者的高复发感染率,需要进一步研究HHT患者的预防策略。
{"title":"A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study","authors":"Eloïse Le Banner ,&nbsp;Joseph Le Moulec ,&nbsp;Mallorie Kerjouan ,&nbsp;Vincent Grosbost ,&nbsp;Antoine Parrot ,&nbsp;Murielle Rondeau-Lutz ,&nbsp;Vanessa Leguy Seguin ,&nbsp;Christian Lavigne ,&nbsp;Anne Contis ,&nbsp;Morgane Mourguet ,&nbsp;Shirine Mohamed ,&nbsp;Étienne-Marie Jutant ,&nbsp;Sandra Blivet ,&nbsp;Johana Pradelli ,&nbsp;Olivier Espitia ,&nbsp;Laurent Chaussavoine ,&nbsp;Sabine Revuz ,&nbsp;Matthieu Revest ,&nbsp;Pierre Tattevin ,&nbsp;Sophie Dupuis-Girod ,&nbsp;David Luque Paz","doi":"10.1016/j.jinf.2026.106686","DOIUrl":"10.1016/j.jinf.2026.106686","url":null,"abstract":"<div><h3>Objectives</h3><div>Patients with hereditary hemorrhagic telangiectasia (HHT) present increased risk of severe infections. Studies focusing on infections in HHT population are scarce. We aimed to assess characteristics and outcomes of infections in patients with HHT.</div></div><div><h3>Methods</h3><div>A retrospective study was conducted in a nationwide cohort of 4502 HHT patients. Patients with HHT hospitalized for infection across 16 referral centers in France between 2010 and 2024 were identified, and data were collected through a standardized questionnaire.</div></div><div><h3>Results</h3><div>We included 163 HHT patients (median age, 60 years [49–69], 52% male), who experienced a total of 249 bacterial infections. One third (n=53/163) experienced recurrent infections requiring hospitalization. Infections caused by <em>Staphylococcus aureus</em> were reported in 80 patients representing 107 episodes of infection. Brain abscesses were reported in 43 patients representing 51 episodes, often despite prior pulmonary arteriovenous malformations embolization (n=17/43). In multivariable analysis, factors associated with 1-year mortality (n=27/163, 17%) were age (aHR=1.06, 95%CI:1.01–1.16) and infective endocarditis (aHR=2.88, 95%CI:1.10–7.87).</div></div><div><h3>Conclusions</h3><div>In this HHT cohort, severe infections were predominantly due to <em>S. aureus,</em> far ahead of brain abscesses caused by oral bacteria. Considering the high rate of recurrent infections, further studies focusing on prophylaxis strategies in HHT patients are needed.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106686"},"PeriodicalIF":11.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune profile of T-lymphocytes in pediatric patients recovered of COVID-19: A longitudinal report 儿童COVID-19康复患者t淋巴细胞免疫谱:一项纵向报告。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-14 DOI: 10.1016/j.jinf.2026.106691
Vera Bain, Isabela Silva-Avelar, Simone Correa-Silva, Olivia M. Matsuo, Yingying Zheng, Andreia Rangel-Santos, Guilherme Souza Gonçalves, Thais de Toledo Fink, Priscila Suguita, Juliana Caires O.A. Ferreira, Arthur Eduardo Fernandes Ferreira, Camila Sanson Yoshino de Paula, Camilla Astley, Fernanda Martins, Magda Carneiro-Sampaio, Heloisa Helena de Sousa Marques, Clovis A. Silva, Patricia Palmeira , Maria Fernanda Bádue Pereira
{"title":"Immune profile of T-lymphocytes in pediatric patients recovered of COVID-19: A longitudinal report","authors":"Vera Bain,&nbsp;Isabela Silva-Avelar,&nbsp;Simone Correa-Silva,&nbsp;Olivia M. Matsuo,&nbsp;Yingying Zheng,&nbsp;Andreia Rangel-Santos,&nbsp;Guilherme Souza Gonçalves,&nbsp;Thais de Toledo Fink,&nbsp;Priscila Suguita,&nbsp;Juliana Caires O.A. Ferreira,&nbsp;Arthur Eduardo Fernandes Ferreira,&nbsp;Camila Sanson Yoshino de Paula,&nbsp;Camilla Astley,&nbsp;Fernanda Martins,&nbsp;Magda Carneiro-Sampaio,&nbsp;Heloisa Helena de Sousa Marques,&nbsp;Clovis A. Silva,&nbsp;Patricia Palmeira ,&nbsp;Maria Fernanda Bádue Pereira","doi":"10.1016/j.jinf.2026.106691","DOIUrl":"10.1016/j.jinf.2026.106691","url":null,"abstract":"","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106691"},"PeriodicalIF":11.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A blood-based Xpert host response assay for diagnosis and differentiation of active and latent tuberculosis in children and adolescents: A multi-center, prospective study 儿童和青少年活动性和潜伏性肺结核的诊断和鉴别:一项多中心的前瞻性研究。
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-12 DOI: 10.1016/j.jinf.2026.106678
Lin Sun , Min Fang , Yu Chen , Weiwei Jiao , Tingting Zou , Xiaoru Long , Yuqing Wang , Tingting Jiang , Jing Bi , Xinghui Gao , Mengran Li , Li Duan , Lichao Fan , Yun Qi , Manzhi Wang , Jiayun Shi , Tongqiang Zhang , Yongsheng Xu , Yiwei Tang , Chaomin Wan , Adong Shen

Objectives

Non-sputum based, child-friendly triage tests are urgently needed to achieve accurate diagnosis and monitoring of tuberculosis (TB) in children. We aimed to assess an Xpert MTB Host Response (MTB-HR) assay, which provides a TB score based on the mRNA expression level of three host genes, for diagnosis and differentiation TB in children and adolescents.

Methods

The multicenter, prospective study was conducted in four provinces of China among children and adolescents who were admitted to hospitals for TB or latent tuberculosis infection (LTBI) screening. Subjects were included in the evaluation of Xpert-MTB-HR from February 2020 to December 2021. Baselines of TB scores were analyzed in healthy children and adolescents with various ages. Accuracy was evaluated in subjects with various TB status, including microbiological data, disease severity and age.

Results

Based on a composite clinical reference standard, among 780 patients enrolled, 403, 41, 109, and 227 were diagnosed as TB, LTBI, non-TB infectious diseases (DC) and healthy controls (HC), respectively. The mean TB scores decreased from 4 (IQR, 3·54–4·46) in infants to 0·91 (IQR, −0·23–2·04) in adolescents aged 17–18 years old. Using the composite clinical reference standard, the area under curves (AUCs) of the MTB-HR assay in discriminating ATB from HC, LTBI, and DC were 0·786 (95% CI, 0·749–0·823), 0·652 (95% CI, 0·559–0·744) and 0·771 (95% CI, 0·718–0·823), respectively.The optimal cutoff value was less than or equal to 2·675, resulting a sensitivity of 75·9% (95% CI, 67·0%–80·9%) and specificity of 70·5% (95%CI, 60·3%–76·7%) in TB diagnosis. The MTB-HR assay showed better auxiliary effect for diagnosis of ATB in children younger than five years of age (AUC, 0·885, 95% CI, 0·824–0·945, P=0·0006). The mean TB scores elevated at one month (P=0·0009) and three months (P=0·0061) after anti-TB treatment initiation.

Conclusions

The MTB-HR assay showed potential for ATB diagnosis and treatment monitoring in children and adolescents, especially in ages under five years old.
目的:迫切需要非痰基础、儿童友好的分诊试验,以实现对儿童结核病的准确诊断和监测。我们旨在评估Xpert结核分枝杆菌宿主反应(MTB- hr)检测,该检测基于三种宿主基因的mRNA表达水平提供结核评分,用于儿童和青少年结核病的诊断和鉴别。方法:在中国4个省份开展多中心前瞻性研究,调查住院接受结核病或潜伏性结核感染(LTBI)筛查的儿童和青少年。受试者于2020年2月至2021年12月被纳入expert - mtb - hr评估。对不同年龄的健康儿童和青少年的结核病评分基线进行了分析。对具有不同结核状态的受试者进行准确性评估,包括微生物学数据、疾病严重程度和年龄。结果:根据综合临床参考标准,入组的780例患者中,分别有403例、41例、109例和227例诊断为TB、LTBI、非TB传染病(DC)和健康对照(HC)。婴儿的平均结核评分从4 (IQR, 3.54 - 4.46)下降到17-18岁青少年的0.91 (IQR, - 0.23 - 3.04)。采用综合临床参考标准,MTB-HR法鉴别ATB与HC、LTBI和DC的曲线下面积(auc)分别为0.786 (95% CI, 0.749 ~ 0.823)、0.652 (95% CI, 0.559 ~ 0.744)和0.771 (95% CI, 0.718 ~ 0.823)。最佳临界值小于或等于2.675,诊断结核的敏感性为75.9% (95%CI, 67.0% ~ 80.9%),特异性为77.5% (95%CI, 63% ~ 76.7%)。MTB-HR检测对5岁以下儿童ATB的辅助诊断效果较好(AUC, 0.885, 95% CI, 0.824 - 0.945, P= 0.0006)。在抗结核治疗开始后1个月(P= 0.009)和3个月(P= 0.0061),平均结核评分升高。结论:MTB-HR检测在儿童和青少年,特别是5岁以下儿童中具有诊断和治疗监测的潜力。
{"title":"A blood-based Xpert host response assay for diagnosis and differentiation of active and latent tuberculosis in children and adolescents: A multi-center, prospective study","authors":"Lin Sun ,&nbsp;Min Fang ,&nbsp;Yu Chen ,&nbsp;Weiwei Jiao ,&nbsp;Tingting Zou ,&nbsp;Xiaoru Long ,&nbsp;Yuqing Wang ,&nbsp;Tingting Jiang ,&nbsp;Jing Bi ,&nbsp;Xinghui Gao ,&nbsp;Mengran Li ,&nbsp;Li Duan ,&nbsp;Lichao Fan ,&nbsp;Yun Qi ,&nbsp;Manzhi Wang ,&nbsp;Jiayun Shi ,&nbsp;Tongqiang Zhang ,&nbsp;Yongsheng Xu ,&nbsp;Yiwei Tang ,&nbsp;Chaomin Wan ,&nbsp;Adong Shen","doi":"10.1016/j.jinf.2026.106678","DOIUrl":"10.1016/j.jinf.2026.106678","url":null,"abstract":"<div><h3>Objectives</h3><div>Non-sputum based, child-friendly triage tests are urgently needed to achieve accurate diagnosis and monitoring of tuberculosis (TB) in children. We aimed to assess an Xpert MTB Host Response (MTB-HR) assay, which provides a TB score based on the mRNA expression level of three host genes, for diagnosis and differentiation TB in children and adolescents.</div></div><div><h3>Methods</h3><div>The multicenter, prospective study was conducted in four provinces of China among children and adolescents who were admitted to hospitals for TB or latent tuberculosis infection (LTBI) screening. Subjects were included in the evaluation of Xpert-MTB-HR from February 2020 to December 2021. Baselines of TB scores were analyzed in healthy children and adolescents with various ages. Accuracy was evaluated in subjects with various TB status, including microbiological data, disease severity and age.</div></div><div><h3>Results</h3><div>Based on a composite clinical reference standard, among 780 patients enrolled, 403, 41, 109, and 227 were diagnosed as TB, LTBI, non-TB infectious diseases (DC) and healthy controls (HC), respectively. The mean TB scores decreased from 4 (IQR, 3·54–4·46) in infants to 0·91 (IQR, −0·23–2·04) in adolescents aged 17–18 years old. Using the composite clinical reference standard, the area under curves (AUCs) of the MTB-HR assay in discriminating ATB from HC, LTBI, and DC were 0·786 (95% CI, 0·749–0·823), 0·652 (95% CI, 0·559–0·744) and 0·771 (95% CI, 0·718–0·823), respectively.The optimal cutoff value was less than or equal to 2·675, resulting a sensitivity of 75·9% (95% CI, 67·0%–80·9%) and specificity of 70·5% (95%CI, 60·3%–76·7%) in TB diagnosis. The MTB-HR assay showed better auxiliary effect for diagnosis of ATB in children younger than five years of age (AUC, 0·885, 95% CI, 0·824–0·945, <em>P</em>=0·0006). The mean TB scores elevated at one month (<em>P</em>=0·0009) and three months (<em>P</em>=0·0061) after anti-TB treatment initiation.</div></div><div><h3>Conclusions</h3><div>The MTB-HR assay showed potential for ATB diagnosis and treatment monitoring in children and adolescents, especially in ages under five years old.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106678"},"PeriodicalIF":11.9,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased long-term mortality of patients with prosthetic joint infection after primary total hip arthroplasty – A large observational cohort study 原发性全髋关节置换术后假体关节感染患者的长期死亡率增加——一项大型观察性队列研究
IF 11.9 1区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-12 DOI: 10.1016/j.jinf.2026.106689
Andreas Widmer , Nadine Imhasly , Christian Brand , Vilijam Zdravkovi , Adrian Spoerri , Kurt Schmidlin , Melanie Wicki , Martin Beck , Rami Sommerstein , for SIRIS and SWISSNOSO

Objective

Evaluate long-term mortality and the role of causative pathogens in periprosthetic joint infection (PJI) following total hip arthroplasty (THA).

Methods

Retrospective nationwide cohort study of adults undergoing THA (2012–2022) using data from the Swiss Joint Registry, Center for Infection Prevention and civil registry. Primary outcome was up to 10-year survival with or without PJI. Adjusted hazard ratios (aHR) were estimated via Gompertz regression, controlling for sex, age, BMI, and ASA. Pathogen-specific mortality hazard was analyzed.

Results

Of 215,678 patients, 89,709 met inclusion criteria (51.3% women; median age 69 years). PJI occurred in 745 (0.8%) patients, 2 752 (3.1%) underwent aseptic revision. PJI was associated with increased mortality (aHR 2.15; 95% CI, 1.79–2.57; p<0.001) compared to no PJI/revision, aseptic revisions were not (aHR 0.92; 95% CI, 0.80–1.06; p=0.27). Pathogens associated with increased mortality included Enterobacterales (aHR 3.17; 95% CI, 2.09–4.83, p<0.001), Staphylococcus aureus (aHR 2.32; 95% CI, 1.65–3.27; p<0.001), Cutibacterium acnes (aHR 2.31; 95% CI, 1.20–4.45; p=0.01), and coagulase-negative staphylococci (aHR 1.65; 95% CI, 1.16–2.35; p=0.006). Streptococcal infections showed no significant association (aHR 1.24; 95% CI, 0.62–2.49; p=0.54).

Conclusion

PJI following THA was associated with an approximately twofold increase in long-term mortality hazard. C. acnes presented an unexpectedly high mortality hazard.
目的评价全髋关节置换术(THA)术后假体周围感染(PJI)致病菌的长期死亡率和作用。方法采用瑞士感染预防中心联合登记处和民事登记处的数据,对2012-2022年接受全髋关节置换术的成年人进行回顾性全国队列研究。主要终点是有或没有PJI的10年生存率。校正风险比(aHR)通过Gompertz回归估计,控制性别、年龄、BMI和ASA。分析病原特异性死亡风险。结果215,678例患者中,89,709例符合纳入标准(51.3%为女性,中位年龄69岁)。745例(0.8%)患者发生PJI, 2752例(3.1%)患者进行了无菌翻修。与无PJI/修订相比,PJI与死亡率增加相关(aHR 2.15; 95% CI, 1.79-2.57; p<0.001),无PJI/修订与死亡率增加相关(aHR 0.92; 95% CI, 0.80-1.06; p=0.27)。与死亡率增加相关的病原体包括肠杆菌(aHR 3.17, 95% CI, 2.09-4.83, p=0.006)、金黄色葡萄球菌(aHR 2.32, 95% CI, 1.65 - 3.27, p= 0.001)、痤疮表皮杆菌(aHR 2.31, 95% CI, 1.20-4.45, p=0.01)和凝固酶阴性葡萄球菌(aHR 1.65, 95% CI, 1.16-2.35, p=0.006)。链球菌感染无显著相关性(aHR 1.24; 95% CI, 0.62-2.49; p=0.54)。结论髋关节置换术后pji与长期死亡风险增加约两倍相关。痤疮呈现出出乎意料的高死亡率。
{"title":"Increased long-term mortality of patients with prosthetic joint infection after primary total hip arthroplasty – A large observational cohort study","authors":"Andreas Widmer ,&nbsp;Nadine Imhasly ,&nbsp;Christian Brand ,&nbsp;Vilijam Zdravkovi ,&nbsp;Adrian Spoerri ,&nbsp;Kurt Schmidlin ,&nbsp;Melanie Wicki ,&nbsp;Martin Beck ,&nbsp;Rami Sommerstein ,&nbsp;for SIRIS and SWISSNOSO","doi":"10.1016/j.jinf.2026.106689","DOIUrl":"10.1016/j.jinf.2026.106689","url":null,"abstract":"<div><h3>Objective</h3><div>Evaluate long-term mortality and the role of causative pathogens in periprosthetic joint infection (PJI) following total hip arthroplasty (THA).</div></div><div><h3>Methods</h3><div>Retrospective nationwide cohort study of adults undergoing THA (2012–2022) using data from the Swiss Joint Registry, Center for Infection Prevention and civil registry. Primary outcome was up to 10-year survival with or without PJI. Adjusted hazard ratios (aHR) were estimated via Gompertz regression, controlling for sex, age, BMI, and ASA. Pathogen-specific mortality hazard was analyzed.</div></div><div><h3>Results</h3><div>Of 215,678 patients, 89,709 met inclusion criteria (51.3% women; median age 69 years). PJI occurred in 745 (0.8%) patients, 2 752 (3.1%) underwent aseptic revision. PJI was associated with increased mortality (aHR 2.15; 95% CI, 1.79–2.57; p&lt;0.001) compared to no PJI/revision, aseptic revisions were not (aHR 0.92; 95% CI, 0.80–1.06; p=0.27). Pathogens associated with increased mortality included Enterobacterales (aHR 3.17; 95% CI, 2.09–4.83, p&lt;0.001), <em>Staphylococcus aureus</em> (aHR 2.32; 95% CI, 1.65–3.27; p&lt;0.001), <em>Cutibacterium acnes</em> (aHR 2.31; 95% CI, 1.20–4.45; p=0.01), and coagulase-negative staphylococci (aHR 1.65; 95% CI, 1.16–2.35; p=0.006). Streptococcal infections showed no significant association (aHR 1.24; 95% CI, 0.62–2.49; p=0.54).</div></div><div><h3>Conclusion</h3><div>PJI following THA was associated with an approximately twofold increase in long-term mortality hazard. <em>C. acnes</em> presented an unexpectedly high mortality hazard.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"92 2","pages":"Article 106689"},"PeriodicalIF":11.9,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1